Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Anakinra versus intramuscular methylprednisolone acetate for gout flares in people with chronic kidney disease (ASGARD): a UK randomised multicentre, double-blind, double-dummy controlled feasibility study with economic, qualitative and safety assessment. Local targets link to admitted publications; unresolved targets remain external evidence.
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review
10.1186/s13075-021-02416-y · 2021 · External reference
10.1016/j.amjmed.2010.09.012
10.1016/j.amjmed.2010.09.012 · External reference
10.1016/j.semarthrit.2012.03.013
10.1016/j.semarthrit.2012.03.013 · External reference
10.1038/s41584-020-0441-1
10.1038/s41584-020-0441-1 · External reference
10.1186/s13075-015-0610-9
10.1186/s13075-015-0610-9 · External reference
10.1093/rheumatology/keq363
10.1093/rheumatology/keq363 · External reference
10.1002/art.27327
10.1002/art.27327 · External reference
10.1136/annrheumdis-2019-216154
10.1136/annrheumdis-2019-216154 · External reference
Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis
1994 · External reference
10.1136/annrheumdis-2011-200908
10.1136/annrheumdis-2011-200908 · External reference
10.1186/ar3297
10.1186/ar3297 · External reference
10.1016/s0140-6736(08)60799-0
10.1016/s0140-6736(08)60799-0 · External reference
Unresolved reference
External reference
10.1038/nature04516
10.1038/nature04516 · External reference
10.1002/art.27600
10.1002/art.27600 · External reference
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares
10.1002/art.41699 · 2021 · External reference
10.1002/art.33412
10.1002/art.33412 · External reference
Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study
10.1002/acr.21690 · 2012 · External reference
Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
10.1186/ar4159 · 2023 · External reference
10.1136/ard.2010.144063
10.1136/ard.2010.144063 · External reference
10.1186/ar2143
10.1186/ar2143 · External reference
Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study
10.1016/j.jbspin.2018.03.015 · 2018 · External reference
10.1093/rheumatology/key402
10.1093/rheumatology/key402 · External reference
10.1136/bmjopen-2017-017121
10.1136/bmjopen-2017-017121 · External reference
Unresolved reference
External reference
10.3899/jrheum.131246
10.3899/jrheum.131246 · External reference
10.1002/pst.185
10.1002/pst.185 · External reference
The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout
2008 · External reference
10.3899/jrheum.131244
10.3899/jrheum.131244 · External reference
10.1007/s11136-011-9903-x
10.1007/s11136-011-9903-x · External reference
10.1016/j.jval.2012.02.008
10.1016/j.jval.2012.02.008 · External reference
The Lower Extremity Functional Scale: Scale development, measurement properties, and clinical application
1999 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1136/annrheumdis-2013-204463
10.1136/annrheumdis-2013-204463 · External reference
10.3399/bjgp18x697997
10.3399/bjgp18x697997 · External reference
10.3899/jrheum.190257
10.3899/jrheum.190257 · External reference
